UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 261

Sortiert nach

Performance of Candidate Serum Biomarkers for Systemic Sclerosis–Associated Interstitial Lung Disease

Arthritis & rheumatology (Hoboken, N.J.), 2019-06, Vol.71 (6), p.972-982

2019

Link zum Volltext

Verfügbarkeit prüfen

Mycophenolate Mofetil Versus Placebo for Systemic Sclerosis–Related Interstitial Lung Disease: An Analysis of Scleroderma Lung Studies I and II

Arthritis & rheumatology (Hoboken, N.J.), 2017-07, Vol.69 (7), p.1451-1460

2017

Link zum Volltext

Verfügbarkeit prüfen

Tracking Impact of Interstitial Lung Disease in Systemic Sclerosis in a Complete Nationwide Cohort

American journal of respiratory and critical care medicine, 2019-11, Vol.200 (10), p.1258-1266

2019

Link zum Volltext

Verfügbarkeit prüfen

CCL21 as a Potential Serum Biomarker for Pulmonary Arterial Hypertension in Systemic Sclerosis

Arthritis & rheumatology (Hoboken, N.J.), 2018-10, Vol.70 (10), p.1644-1653

2018

Link zum Volltext

Verfügbarkeit prüfen

Anticentromere Antibody Levels and Isotypes and the Development of Systemic Sclerosis

Arthritis & rheumatology (Hoboken, N.J.), 2021-12, Vol.73 (12), p.2338-2347

2021

Link zum Volltext

Verfügbarkeit prüfen

Predictive Value of Serial High‐Resolution Computed Tomography Analyses and Concurrent Lung Function Tests in Systemic Sclerosis

Arthritis & rheumatology (Hoboken, N.J.), 2015-08, Vol.67 (8), p.2205-2212

2015

Link zum Volltext

Verfügbarkeit prüfen

Multidimensional tracking of phenotypes and organ involvement in a complete nationwide systemic sclerosis cohort

Rheumatology (Oxford, England), 2020-10, Vol.59 (10), p.2920-2929

2020

Link zum Volltext

Verfügbarkeit prüfen

Dupilumab (Dupixent®) tends to be an effective therapy for uncontrolled severe chronic rhinosinusitis with nasal polyps: real data of a single-centered, retrospective single-arm longitudinal study from a university hospital in Germany

European archives of oto-rhino-laryngology, 2023-04, Vol.280 (4), p.1741-1755

2023

Link zum Volltext

Verfügbarkeit prüfen

High Level of Chemokine CCL18 Is Associated With Pulmonary Function Deterioration, Lung Fibrosis Progression, and Reduced Survival in Systemic Sclerosis

Chest, 2016-08, Vol.150 (2), p.299-306

2016

Link zum Volltext

Verfügbarkeit prüfen

Performance of the 2013 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Systemic Sclerosis (SSc) in large, well-defined cohorts of SSc and mixed connective tissue disease

Journal of rheumatology, 2015-01, Vol.42 (1), p.60

2015

Link zum Volltext

Verfügbarkeit prüfen

Role of Stromelysin 2 (Matrix Metalloproteinase 10) as a Novel Mediator of Vascular Remodeling Underlying Pulmonary Hypertension Associated With Systemic Sclerosis

Arthritis & rheumatology (Hoboken, N.J.), 2017-11, Vol.69 (11), p.2209-2221

2017

Link zum Volltext

Verfügbarkeit prüfen

HPV status in patients with head and neck of carcinoma of unknown primary site: HPV, tobacco smoking, and outcome

Oral oncology, 2012-11, Vol.48 (11), p.1178-1184

2012

Link zum Volltext

Verfügbarkeit prüfen

Augmented concentrations of CX3CL1 are associated with interstitial lung disease in systemic sclerosis

PloS one, 2018, Vol.13 (11), p.e0206545-e0206545

2018

Link zum Volltext

Verfügbarkeit prüfen

Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database

Annals of the rheumatic diseases, 2021-02, Vol.80 (2), p.219

2021

Link zum Volltext

Verfügbarkeit prüfen

The antileukoprotease secretory leukocyte protease inhibitor (SLPI) and its role in the prevention of HPV-infections in head and neck squamous cell carcinoma

Cancer letters, 2015-02, Vol.357 (1), p.339-345

2015

Link zum Volltext

Verfügbarkeit prüfen

Prediction of progression of interstitial lung disease in patients with systemic sclerosis: the SPAR model

Annals of the rheumatic diseases, 2018-09, Vol.77 (9), p.1326

2018

Link zum Volltext

Verfügbarkeit prüfen

Left Ventricular Diastolic Dysfunction Predicts Mortality in Patients With Systemic Sclerosis

Journal of the American College of Cardiology, 2018-10, Vol.72 (15), p.1804-1813

2018

Link zum Volltext

Verfügbarkeit prüfen

Dr. Hoffmann-Vold replies

Journal of rheumatology, 2015-12, Vol.42 (12), p.2513

Hoffmann-Vold, Anna-Maria

2015

Link zum Volltext

Verfügbarkeit prüfen

Survival and causes of death in an unselected and complete cohort of Norwegian patients with systemic sclerosis

Journal of rheumatology, 2013-07, Vol.40 (7), p.1127

2013

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of infectious diseases, immunity to vaccine-preventable diseases and chronic medical conditions among Ukrainian refugees in Germany – A cross sectional study from the German Network University Medicine (NUM)

Journal of infection and public health, 2024-04, Vol.17 (4), p.642-649

2024

Link zum Volltext

Verfügbarkeit prüfen

The phenotype of mixed connective tissue disease patients having associated interstitial lung disease

Seminars in arthritis and rheumatism, 2023-12, Vol.63, p.152258-152258, Article 152258

2023

Link zum Volltext

Verfügbarkeit prüfen

Estimated glomerular filtration rate is a marker of mortality in the European Scleroderma Trials and Research Group (EUSTAR) database

Rheumatology (Oxford, England), 2021-12, Vol.61 (1), p.213-222

2021

Link zum Volltext

Verfügbarkeit prüfen

Representativeness of systemic sclerosis patients in interventional randomized trials: an analysis of the EUSTAR database

Rheumatology, 2022-02, Vol.61 (2), p.743-755

2022

Link zum Volltext

Verfügbarkeit prüfen

Endotype–phenotyping may predict a treatment response in progressive fibrosing interstitial lung disease

EBioMedicine, 2019-12, Vol.50, p.379-386

2019

Link zum Volltext

Verfügbarkeit prüfen

Cardiopulmonary Disease Development in Anti-RNA Polymerase III-positive Systemic Sclerosis: Comparative Analyses from an Unselected, Prospective Patient Cohort

Journal of rheumatology, 2017-04, Vol.44 (4), p.459

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 261

Suche als RSS-Feed

Aktive Filter

SpracheDeutsch

SprachePortugiesisch

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(258)
Mit Volltextzugriff
(226)

Publikationsform

Artikel
(261)

Sprache

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Performance of Candidate Serum Biomarkers for Systemic Sclerosis–Associated Interstitial Lung Disease

Mycophenolate Mofetil Versus Placebo for Systemic Sclerosis–Related Interstitial Lung Disease: An Analysis of Scleroderma Lung Studies I and II

Tracking Impact of Interstitial Lung Disease in Systemic Sclerosis in a Complete Nationwide Cohort

CCL21 as a Potential Serum Biomarker for Pulmonary Arterial Hypertension in Systemic Sclerosis

Anticentromere Antibody Levels and Isotypes and the Development of Systemic Sclerosis

Predictive Value of Serial High‐Resolution Computed Tomography Analyses and Concurrent Lung Function Tests in Systemic Sclerosis

Multidimensional tracking of phenotypes and organ involvement in a complete nationwide systemic sclerosis cohort

Dupilumab (Dupixent®) tends to be an effective therapy for uncontrolled severe chronic rhinosinusitis with nasal polyps: real data of a single-centered, retrospective single-arm longitudinal study from a university hospital in Germany

High Level of Chemokine CCL18 Is Associated With Pulmonary Function Deterioration, Lung Fibrosis Progression, and Reduced Survival in Systemic Sclerosis

Performance of the 2013 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Systemic Sclerosis (SSc) in large, well-defined cohorts of SSc and mixed connective tissue disease

Role of Stromelysin 2 (Matrix Metalloproteinase 10) as a Novel Mediator of Vascular Remodeling Underlying Pulmonary Hypertension Associated With Systemic Sclerosis

HPV status in patients with head and neck of carcinoma of unknown primary site: HPV, tobacco smoking, and outcome

Augmented concentrations of CX3CL1 are associated with interstitial lung disease in systemic sclerosis

Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database

The antileukoprotease secretory leukocyte protease inhibitor (SLPI) and its role in the prevention of HPV-infections in head and neck squamous cell carcinoma

Prediction of progression of interstitial lung disease in patients with systemic sclerosis: the SPAR model

Left Ventricular Diastolic Dysfunction Predicts Mortality in Patients With Systemic Sclerosis

Dr. Hoffmann-Vold replies

Survival and causes of death in an unselected and complete cohort of Norwegian patients with systemic sclerosis

Prevalence of infectious diseases, immunity to vaccine-preventable diseases and chronic medical conditions among Ukrainian refugees in Germany – A cross sectional study from the German Network University Medicine (NUM)

The phenotype of mixed connective tissue disease patients having associated interstitial lung disease

Estimated glomerular filtration rate is a marker of mortality in the European Scleroderma Trials and Research Group (EUSTAR) database

Representativeness of systemic sclerosis patients in interventional randomized trials: an analysis of the EUSTAR database

Endotype–phenotyping may predict a treatment response in progressive fibrosing interstitial lung disease

Cardiopulmonary Disease Development in Anti-RNA Polymerase III-positive Systemic Sclerosis: Comparative Analyses from an Unselected, Prospective Patient Cohort

Aktive Filter

Suchergebnisse filtern